Uncommon Therapeutics
A Disease Focused Biotech, Building Multiple Billion Dollar Drugs
About
Our founder Noah, an experienced tech entrepreneur, was directly impacted by a severe genetic disease when his daughter was diagnosed with Rett Syndrome, a disease that afflicts 1 in 10,000 girls. Using an innovative polytherapy strategy, we’ve successfully improved her quality of life, and have designed new therapeutics that each could be worth billions and together could deliver a cure.
Topics
- Location
- San Francisco, CA, United States
- Team size
- 2 employees
- YC batch
- Winter 2025
- Status
- Active
- Stage
- Early stage
